Abstract Book Click    List of Poster Presentations Click    Social Program Click    The Instructions for Oral & Poster Presentation Click    The Final Programme Click

AFMC President & Symposium Chair Esin AKI-YALCIN
Prof. (PhD)
Ankara University - Turkey


Organization Committee Chair of the AIMECS 2019 Ismail YALÇIN
Prof. (PhD)
Ankara University - Turkey


Symposium Secretariat Sinan SENEM Phone :
+90 312 419 0 998
Fax :
+90 312 419 1 888
info@aimecs2019.org



MANAGED BY


SPONSORS

List of Poster Presentation

Poster No Abstract Title & Author
01 EU-OPENSCREEN - INNOVATIVE COLLABORATION MODELS IN EARLY DRUG DISCOVERY
Stechmann BAHNE (EU-Openscreen, Berlin, Germany)
02 TARGETED THERAPY OF BREAST CANCER USING IMMUNE CHEMO THERAPEUTIC AGENTS LOADED MESOPOROUS SILICA MAGNETIC NANOPARTICLES
Nastaran HASHEMZADEH (Tabriz University of Medical Sciences, Tabriz, Iran)
03 A NOVEL CEREBLON MODULATOR FOR TARGETED PROTEIN DEGRADATION
Ahra GO (Korea Research Institute of Chemical Technology, Daejeon, South Korea)
04 A FOUR STEP MICROWAVE-MEDIATED SYNTHESIS, ENZYMATIC ASSAY OF NEW TRIAZOLE SCAFFOLD DERIVATIVES AS FACTOR Xa INHIBITORS VS ANTIBACTERIAL ACTIVITY ASSAYS
Flavia ZACCONI (Pontificia Universidad Católica de Chile)
05 A THREE-STEP MICROWAVE-MEDIATED SYNTHESIS OF NOVEL N-ALLYL/PROPARGYL TETRAHYDROQUINOLINE DERIVATIVES: COMPUTATIONAL STUDY AND ENZYMATIC ANALYSIS AS A POTENTIAL FACTOR XA INHIBITOR
Flavia ZACCONI (Pontificia Universidad Católica de Chile)
06 THE IDENTIFICATION OF NATURALLY OCCURRING LABDANE DITERPENOID CALCARATARIN D AS A POTENTIAL ANTI-INFLAMMATORY AGENT
Thi Ngoc Quy TRAN (National University of Singapore, Singapore, Singapore)
07 HIJACKING THE ARYL HYDROCARBON RECEPTOR PATHWAY AS A BREAST CANCER DRUG TARGET
Jennifer BAKER (University Of Newcastle, Callaghan, Australia)
08 DESIGN AND SYNTHESES OF 1-HETEROARYL-2-ARYL-BICYCLO DERIVATIVES AS CNS PROTEIN KINASE INHIBITORS
Miyoung JANG (Hanyang University, Ansan, South Korea)
09 DISCOVERY OF NOVEL SELECTIVE FLT3 INHIBITORS
Daseul IM (Hanyang University, Ansan, South Korea)
10 REGIOSELECTIVE SYNTHESES OF HIGHLY SUBSTITUTED PYRAZOLES AS PRIVILEGED SCAFFOLD
Youri OH (Hanyang University, Ansan, South Korea)
11 COMPUTATIONAL STUDY OF THE INHIBITION OF N- TERMINAL HUMAN MALTASE GLUCOAMYLASE USING VIRTUAL SCREENING BASED ON STRUCTURE AND LIGAND
Ferkous FOUAD (Université De Annaba, Annaba, Algeria)
12 DEVELOPMENT OF NOVEL BIASED AGONISTS AGAINST S1P1 RECEPTOR FOR TREATMENT OF MULTIPLE SCLEROSIS
Sun Jun PARK (Korea University of Science and Technology, Seoul, South Korea)
13 IDENTIFICATION OF ANAPLASTIC LYMPHOMA KINASE INHIBITORS BY STRUCTURE-BASED DRUG DESIGN
Shinmee MAH (Institute Of Basic Science, Daejeon, South Korea)
14 ENANTIOSELECTIVE SYNTHESIS OF α, α DIALKYLMALONATES BY PHASE TRANSFER CATALYTIC α ALKYLATION
Jeongwoo BAN (Seoul National University, Seoul, South Korea)
15 ENANTIOSELECTIVE SYNTHESIS OF CHIRAL α-ALKYLTHIOMALONATES VIA PHASE-TRANSFER CATALYZED α -SULFENYLATION OF α-ALKYLMALONATES
Sangki LEE (Seoul National University, Seoul, South Korea)
16 HISPIDOL ANALOGUES AS SELECTIVE MAO-B INHIBITORS FOR DEVELOPMENT OF POTENTIAL THERAPEUTICS
Kun Won LEE (Kyung Hee University, Seoul, South Korea)
17 DEVELOPMENT OF DERIVATIVES OF SULFURETIN ANALOGUES AS MULTIFUNCTIONAL MAO-B / ACETYLCHOLINESTERASE INHIBITORS FOR MANAGEMENT OF NEURODEGENERATIVE DISEASES
Youngdo JEONG (Kyung Hee University, Seoul, South Korea)
18 IN VIVO COMPUTATIONAL AND PHYSIOLOGICAL ASSESSMENT OF HIPPOCAMPAL MEMBRANE POTENTIALS OF PYRAMIDAL NEURONS DURING ATROPINE-SENSITIVE EXTRACELLULAR THETA OSCILLATIONS
Nobuyoshi MATSUMOTO (University of Tokyo, Tokyo, Japan)
19 EFFICIENT SYNTHETIC METHODS TO CONSTRUCT SUBSTITUTED N-HYDROXYINDOLES AND N-ALKOXYINDOLES
Ye Eun KİM (Duksung Women's University, Seoul, South Korea)
20 NOVEL BENZOFURAN DERIVATIVE DK-1014 WITH POTENT ANTI-INFLAMMATORY PROPERTIES ATTENUATES LUNG INFLAMMATION
Qili LU (Dongguk University, Goyang, South Korea)
21 DEVELOPMENT OF NEW AIMP2-DX2 ANALOGUES AS POTENTIAL ANTICANCER AGENTS
Hwayoung LEE (Dongguk University, Goyang, South Korea)
22 NEUROPHYSIOLOGICAL ASSESSMENT OF HERBAL EFFECT ON THE CENTRAL NERVOUS SYSTEM OF A FREELY MOVING RAT
Kotaro YAMASHIRO (University of Tokyo, Tokyo, Japan)
23 STRUCTURE-BASED DE NOVO DESIGN OF POTENT AND SELECTIVE INHIBITORS FOR EGFR DEL19/T790M/C797S MUTANT
Hoi-Yun JUNG (Korea Advanced Institute Of Science And Technology, Daejeon, South Korea)
24 SYNTHESIS OF FOSMIDOMYCIN ANALOGUES, HYBRIDS AND CONJUGATES WITH 7-CHLOROQUINOLINE AND ARTEMISININ AS PROMISING ANTIMALARIAL AGENTS
Constantinos ATHANASSOPOULOS (University of Patras, Patras, Greece)
25 LIQUID PHASE FRAGMENT SYNTHESIS OF ORTHOGONALLY PROTECTED POLYAMINES AND SPIDER TOXINS WITH POTENTIAL ANTICANCER INTEREST
Constantinos ATHANASSOPOULOS (University of Patras, Patras, Greece)
26 IMPRESSIVE ENRICHMENT OF SEMIEMPIRICAL QUANTUM MECHANICS-BASED SCORING FUNCTION
Cemal KOPRULUOGLU (Institute of Organic Chemistry and Biochemistry of the CAS, Prague, Czech Republic)
27 MODELING THE INTERACTIONS BETWEEN INSULIN RECEPTOR AND INSULIN SITE2 ANALOGS
Anja MUZDALO (Institute of Organic Chemistry and Biochemistry of the CAS, Prague, Czech Republic)
28 INACTIVATION OF MYOSTATIN BY PHOTO-OXYGENATION USING CATALYST-PEPTIDE CONJUGATE
Atsuhiko TANIGUCHI (Tokyo University of Pharmacy And Life Sciences, Tokyo, Japan)
29 DUAL-ACTING INHIBITORS OF WNT/BETA-CATENIN SIGNALING PATHWAY VIA SCLEROSTIN AND LRP5/6 INTERACTION TO STIMULATE BONE FORMATION
Wipawadee YOOIN (Chiang Mai University, Chiang Mai, Thailand)
30 HALF-SANDWICH THIABENDAZOLE RUTHENIUM (II) AND IRIDIUM (III) COMPLEXES INDUCE DNA COMPACTION AND DENATURATION DUE TO METAL-DNA COVALENT BOND
Begoña GARCíA (University of Burgos, Burgos, Spain)
31 COMPUTATIONAL STUDIES OF THE INTERACTION OF RUTHENIUM (II) AND IRIDIUM (III) HALF-SANDWICH COMPLEXES AND β-DNA
José M. LEAL (University of Burgos, Burgos, Spain)
32 ENANTIOSELECTIVE SYNTHESIS OF 4,5-DISUBSTITUTED GAMMA-BUTYROLACTONES BY N-HETEROCYCLE CARBENE-CATALYZED HOMOENOLATE ANNULATION DIRECTLY FROM ENALS AND ALDEHYDES
Tetsuo NARUMİ (Shizuoka University, Hamamatsu, Japan)
33 ADME/TOX EVALUATION OF H2S-RELEASING DOXORUBICIN AS A PROMISING LEAD, EFFECTIVE AGAINST DOXORUBICIN-RESISTANT CELLS: IN SILICO AND IN VITRO STUDIES
Ivanka TSAKOVSKA (Bulgarian Academy of Sciences, Sofia, Bulgaria)
34 FROM SINGLE TO MULTI-TARGET ACTIVE LIGANDS AGAINST NEURODEGENERATIVE DISEASES: MULTI-POTENCY SCREENING AND VIRTUAL ACTIVITY EVALUATION
Ivanka TSAKOVSKA (Bulgarian Academy of Sciences, Sofia, Bulgaria)
35 IN SEARCH FOR MULTITARGET LEADS FOR TREATING NEURODEGENERATIVE DISORDERS: STRUCTURE-BASED PHARMACOPHORE MODELLING AND VIRTUAL SCREENING
Ilza PAJEVA (Bulgarian Academy of Sciences, Sofia, Bulgaria)
36 HEALTHY FOODS FOR A STRONG BIO-ECONOMY AND QUALITY OF LIFE: BUILDING A KNOWLEDGE-BASED STRATEGY IN BULGARIA
Ilza PAJEVA (Bulgarian Academy of Sciences, Sofia, Bulgaria)
37 ON THE APPLICABILITY OF INTERCRITERIA ANALYSIS APPROACH TO THE PERFORMANCE OF AMMOS2 SOFTWARE PLATFORM FOR POST-DOCKING OPTIMIZATION
Vassia ATANASSOVA (Bulgarian Academy of Sciences, Sofia, Bulgaria)
38 SYNTHESIS OF SOME KHELLIN DERIVATIVES AS ALDOSE REDUCTASE ENZYME INHIBITORS
Meltem CEYLAN-UNLUSOY (Ankara University, Ankara, Turkey)
39 IMPROVEMENT OF MEMBRANE PERMEABILITY OF CYCLIC PEPTIDES BY CONFORMATIONAL RESTRICTION USING CYCLOPROPANE
Mizuki WATANABE (Hokkaido University, Sapporo, Japan)
40 TAU-TARGETED DRUG DISCOVERY AS A POTENTIAL TREATMENT OF ALZHEIMER'S DISEASE
Ae Nim PAE (Korea Institute of Science And Technology, Seoul, South Korea)
41 SYNTHESIS OF THIOHYDANTOIN DERIVATIVES FOR THE DEVELOPMENT OF NADPH OXIDASE(NOX) INHIBITOR AS POTENT THERAPEUTIC AGENTS.
Hyemi KIM (Korea University, Seoul, South Korea)
42 DISCOVERY OF LEAD COMPOUND FOR DEVELOPMENT OF DRUG TARGETING FOR SEVERE ASTHMA
Hyejun PARK (Korea University, Seoul, South Korea)
43 SYNTHESIS OF NOVEL TRIAZOLYL-THIAZOLE DERIVATIVES AS ALDOSE REDUCTASE ENZYME INHIBITORS
Oya BOZDAG-DUNDAR (Ankara University, Ankara, Turkey)
44 COMPREHENSIVE BINDING MODE ANALYSIS OF 1,1,3-TRISUBSTITUTED THIOUREA COMPOUNDS FOR HUMAN GLUTAMINYL CYCLASE INHIBITOR DESIGN
Hyerim CHANG (Ewha Womans University, Seoul, South Korea)
45 DESIGN, AND DEVELOPMENT OF SMART NANOPARTICLES FOR ENHANCED ANTI-CANCER ACTIVITY AND REDUCED CARDIOTOXICITY ASSOCIATED WITH THE TYROSINE KINASE INHIBITOR
Zain ZAKARIA (Qatar University, Doha, Qatar)
46 TANDEM C-H ALLYLATION AND [3+2] DIPOLAR CYCLOADDITION OF (HETERO)ARYL AZOMETHINE IMINES WITH ALLYLIC ACETALS USING RU(II)-CATALYST
Neeraj Kumar MISHRA (Sungkyunkwan University, Suwon, South Korea)
47 ANTIOXIDANT, ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITION PROFILES OF NEW BIS-BENZENESULFONAMIDE SCHIFF BASE DERIVATIVES
Gonul YAPAR (Istanbul Technical University, Istanbul, Turkey)
48 ANTIOXIDANT, ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITION PROFILES OF AROMATIC BIS-SULFONAMIDE SCHIFF BASES
Gonul YAPAR (Istanbul Technical University, Istanbul, Turkey)
49 CELL-TYPE-SPECIFIC PATTERNED ACTIVITIES SPECIFY GENE EXPRESSION PATTERNS FOR OLFACTORY CIRCUIT FORMATION
Haruki TAKEUCHI (The University of Tokyo, Tokyo, Japan)
50 AUXIN-MEDIATED RAPID DEGRADATION OF TARGET PROTEINS IN HIPPOCAMPAL NEURONS
Risako NAKANO (The University Of Tokyo, Tokyo, Japan)
51 TOWARDS UNEXPLORED REGIONS OF DRUG-LIKE CHEMICAL SPACE NOVEL FUNCTIONAL SCAFFOLDS BASED ON SPIROCYCLIC AND FUSED CYCLOPROPANES
Karen TARASENKO (Enamine Ltd, Kyiv, Ukraine)
52 SYNTHESIS OF TRIFLUOROMETHYLPYRROLES VERIFICATION OF PREVIOUS DATA
Karen TARASENKO (Enamine Ltd, Kyiv, Ukraine)
53 RETINOIC ACID DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS: DESIGN, SYNTHESIS AND ANTICANCER EVALUATION
Atefeh HAJIAGHA BOZORGI (Alborz University of Medical Sciences, Karaj, Iran)
54 MOLECULAR MODELING STUDIES OF SOME NOVEL HETEROCYCLIC COMPOUNDS AS CHOLINESTERASE INHIBITORS
Dilara EREN (Ankara University, Ankara, Turkey)
55 SYNTHESIS OF SOME BENZOXAZOLE DERIVATIVES AND THEIR DNA TOPOISOMERASE II INHIBITORY ACTIVITY
Muhammed Tilahun MUHAMMED (Suleyman Demirel University, Isparta, Turkey)
56 AN IN SILICO INVESTIGATION OF THE ACTIVATION MECHANISMS OF CLOTTING PROCESSES BY HIGHLY DEACETYLATED OLIGOMERIC CHITOSAN
Sitki Doga ELCI (Lumilabs, Ankara, Turkey)
57 ATOTAL SYNTHESIS OF NATURAL COMPOUNDS USING AN EFFICIENT ONE-POT SYNTHESIS OF 2-BROMO-6-HYDROXYBENZOFURANS
Jiyoon KANG (Dongguk University, Goyang-Si, South Korea)
58 SITE-SELECTIVE C-H ALKYLATION OF HETEROCYCLIC N-OXIDES USING PHOSPHONIUM YLIDES
Saegun KİM (Sungkyunkwan University, Suwon, South Korea)

ORGANISED BY

  • Asian Federation for Medicinal Chemistry

SUPPORTED BY

  • European Federation for Medicinal Chemistry

  • American Chemical Society

  • Pharmaceutical Manufacturers Association of Turkey

  • Association of Research-Based Pharmaceutical Companies

EXHIBITORS


MEDIA PARTNERS